The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial
Publication date: July 2024
Source: Osteoarthritis and Cartilage, Volume 32, Issue 7
Author(s): Asger R. Bihlet, Inger Byrjalsen, Jeppe R. Andersen, Alan Reynolds, Nicholas Larkins, Peter Alexandersen, Helene Rovsing, Robert Moots, Philip G. Conaghan